Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 388 of 5804
-
Can radiation plus immunotherapy shrink recurrent head and neck tumors before surgery?
Disease control Recruiting nowThe purpose of the Phase I study is to see if it is safe to use X-ray photon radiation (XRT) and proton radiation (PT) before surgery in patients with recurrent head and neck squamous cell carcinoma (rHNSCC). The purpose of the Phase II study is to see if using XRT or PT before …
Phase: PHASE1, PHASE2 • Sponsor: University of Cincinnati • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could your own cells replace insulin shots? early trial aims to find out
Disease control ENROLLING_BY_INVITATIONThis study aims to conduct an exploratory clinical trial recruiting insulin-dependent diabetic patients who meet the criteria for islet transplantation. Pancreatic tissue will be obtained via endoscopic ultrasound-guided fine-needle aspiration biopsy, and adult pancreatic progeni…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could fewer radiation sessions be just as effective for bladder cancer?
Disease control Recruiting nowThis phase III trial compares the effect of decreased number of radiation (ultra-hypofractionated) treatments to the usual radiation number of treatments (hypofractionation) with standard of care chemotherapy, with cisplatin, gemcitabine or mitomycin and 5-fluorouracil for the tr…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of modified immune cells (IL13Ralpha2 CAR T cells) after a chemotherapy conditioning regimen for the treatment of patients with stage IIIC or IV melanoma or solid tumors that have spread to other places in the body (metast…
Phase: PHASE1 • Sponsor: Anusha Kalbasi • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New combo therapy aims to tackle rare brain cancer
Disease control Not yet recruitingTo evaluate the efficacy and safety of relmacabtagene autoleucel combined with autologous hematopoietic stem cell transplantation, orelabrutinib, and sintilimab as first-line or relapsed/refractory treatment for primary central nervous system diffuse large B-cell lymphoma.
Phase: NA • Sponsor: Zhengzhou University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug cocktail ViPOR targets tough lymphomas in phase II trial
Disease control Recruiting nowThis phase II trial tests how well venetoclax, ibrutinib, prednisone, obinutuzumab, and Revlimid® (ViPOR) works in treating patients with CD10 negative diffuse large B-cell lymphoma (DLBCL) and high-grade lymphoma with MYC and BCL2 rearrangements that has come back after a period…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New combo aims to tackle Hard-to-Treat myeloma
Disease control Recruiting nowThe purpose of this study is to evaluate the preliminary safety and determine the RP2D of mezigdomide in combination with elranatamab in participants with relapsed and refractory multiple myeloma (RRMM).
Phase: PHASE1, PHASE2 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Magic mushroom compound takes on opioid crisis in new trial
Disease control Recruiting nowInvestigators will recruit 36 individuals on MAT for OUD for a double-blind, placebo-controlled design to determine whether PEX010 (25-mg/d) shows preliminary efficacy on neural correlates of neurocognition and on clinical outcomes. Participants will be randomized to either (sing…
Phase: PHASE2 • Sponsor: Anna Rose Childress, Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Heart alert: new study aims to prevent organ damage in sickle cell patients
Disease control Recruiting nowThis study tests whether early heart screening and treatment for iron overload in subjects with sickle cell disease can prevent heart problems and reduce hospitalizations.
Phase: PHASE2 • Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for advanced breast cancer: experimental drug combo enters human trials
Disease control Recruiting nowThe purpose of this study is to assess the safety of GDC-4198 alone and in combination with giredestrant and also the efficacy of GDC-4198 + giredestrant versus abemaciclib + giredestrant in participants with locally advanced or metastatic ER+, HER2- breast cancer. The study cons…
Phase: PHASE1, PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug cocktail aims to shrink lung tumors in Late-Stage trial
Disease control Recruiting nowThis is an exploratory, signal-finding, randomized, placebo-controlled, blinded, multi-center phase 2b trial of the anti-GDF-15 antibody Visugromab (CTL-002) at two different dose levels plus Nivolumab with Docetaxel versus Visugromab at the higher dose plus Nivolumab with placeb…
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug combo shows promise against tough head and neck cancers
Disease control Recruiting nowThe purpose of this study is to assess the objective response rate following neoadjuvant therapy with volrustomig, paclitaxel, and carboplatin in previously untreated human papillomavirus (HPV)-negative locally advanced head and neck squamous cell carcinoma .
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New AI-Powered 'Eye' could slash repeat breast cancer surgeries
Diagnosis Recruiting nowBreast-conserving surgery (lumpectomy) aims to remove cancer while preserving healthy tissue, but up to 20% of patients require a second operation because cancer cells remain at the edge (margin) of the removed tissue. The Spectra-BREAST study evaluates a new optical device that …
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Robots with skin and stem cells get paid in crypto to work in hospitals
Disease control ENROLLING_BY_INVITATIONThis clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biot…
Phase: PHASE2 • Sponsor: Truway Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Surgery before IVF may boost baby chances for endometriosis patients
Disease control Recruiting nowEndometriosis is a chronic disease affecting approximately 10% of women of reproductive age. It is strongly associated with pelvic pain and infertility. Women with advanced stages of the disease (stage III-IV) have markedly reduced fertility compared with the general population. …
Phase: NA • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New cord blood booster aims to make cancer transplants safer and faster
Disease control Recruiting nowThis clinical study is testing a new way to improve stem cell transplants for adults with high-risk blood cancers, such as leukemia or myelodysplasia, who do not have a suitable donor. The transplant uses stem cells from umbilical cord blood that have been expanded in the lab usi…
Phase: PHASE1, PHASE2 • Sponsor: Ciusss de L'Est de l'Île de Montréal • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a single antibiotic dose after sex stop STIs?
Prevention Recruiting nowThe objective of this research is to evaluate the efficacy and safety of doxycycline in MSM for preventing sexually transmitted infections (gonorrhea, chlamydia, and syphilis) in Thailand Participation in this study will last approximately 12 weeks and will include 2-3 clinic vi…
Phase: PHASE4 • Sponsor: Bangrak STIs Center • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC
-
New drug could keep stents open after stroke, reducing need for rescue therapy
Disease control Recruiting nowCo-STAR is a multicenter, prospective, open-label, Bayesian Optimal Phase 2 (BOP2) trial that aims to assess the safety and efficacy of adjunctive intravenous TBO-309 in Acute Ischaemic Stroke (AIS) patients with tandem occlusion receiving intra-cranial endovascular thrombectomy …
Phase: PHASE2 • Sponsor: ThromBio Pty. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New combo therapy tailors radiation for advanced nasopharyngeal cancer
Disease control OngoingThis study is aimed to evaluate the efficacy and safety of tislelizumab combined with chemotherapy and response-adapted radiotherapy in patients with de novo metastatic nasopharyngeal carcinoma
Phase: NA • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a simple pill keep nasopharyngeal cancer away?
Disease control OngoingThis Phase III multicenter trial investigates treatment intensification for high-risk, stage T1-2N1M0 nasopharyngeal carcinoma. Patients with high-risk features (\>3 metastatic lymph nodes, necrosis, or confluence) receive concurrent chemoradiotherapy. Those with detectable EBV D…
Phase: PHASE3 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC